在中度至重度喘患者中,采佩卢马布和粘液塞
Lars H Nordenmark1, Åsa Hellqvist2, Claire Emson3
1Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Oslo.
NEJM evidence
|February 6, 2024
概括
与安慰剂相比,tezepelumab在患有严重喘的成年人中显著减少了粘液塞. 这种喘治疗也改善了肺功能,减少了炎症标志物,为呼吸道阻塞提供了向治疗.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 临床试验 临床试验
- 免疫学 免疫学 免疫学
背景情况:
- 喘中的粘液塞与呼吸道阻塞和IL-5和IL-13等炎症性细胞因子有关.
- 这些粘液塞是新喘治疗的潜在目标.
- 在CASCADE试验中,研究了tzepelumab对非控制性喘患者的粘液塞的影响.
研究的目的:
- 评估tezepelumab在减少中度至重度,不受控制的喘患者的粘液塞的疗效.
- 评估粘液塞得分,炎症生物标志物和肺功能之间的相关性.
- 分析使用计算机断层扫描 (CT) 图像分析tezepelumab的抗炎作用.
主要方法:
- 这是一项双盲,安慰剂对照试验 (CASCADE),涉及82名患有非控制性喘的成年患者.
- 患者每4周服用210毫克特泽佩卢马布或安慰剂,每4周服用一次,至少持续28周.
- 一位专家放射科医生从治疗前和治疗后获得的CT扫描中得分粘液塞.
主要成果:
- 采佩卢马布治疗导致粘液塞得分平均降低-1.7,而安慰剂0.0.
- 基线粘液塞得分与炎症生物标志物 (血液中乙酸氨基,IL-5,IL-13) 有正相关性,肺功能有负相关性.
- 减少粘液塞与tzepelumab与改善的肺功能和降低了eosinophilic生物标志物相关联.
结论:
- 与安慰剂相比,Tezepelumab在中度至重度不受控制的喘中显著减少了封闭性粘液塞.
- 这些发现支持tzepelumab作为喘的向治疗,其特点是粘液堵塞和炎症.
- 进一步的研究可能会验证tzepelumab在治疗有呼吸道阻塞的严重喘方面的作用.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
287
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
287
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
304
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
304
01:20Asthma: Pathogenesis and Management
403
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
403
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K